Centre Testing International Group Co. Ltd. (300012.SZ) Bundle
From a Shenzhen start-up in 2003 to a publicly traded TIC leader (Shenzhen Stock Exchange: 300012) since 2009, Centre Testing International Group Co., Ltd. has grown into a global network of over 160 laboratories and more than 260 offices across 90 cities, serving 100,000+ clients with 4 million+ test and certification reports annually and a workforce exceeding 13,000 professionals; CTI reported operating revenue of CNY 6.084 billion in 2024 (an 8.55% YoY increase) and a TTM revenue of CNY 6.39 billion with net income of CNY 986.61 million, EPS of 0.59 and a P/E of 22.90 as market capitalization stood near CNY 22.57 billion (stock price CNY 13.49 on Dec 19, 2025), while diversifying into textiles, electronics, life sciences, industrial testing, environmental and sustainability verification, and monetizing services across five business segments through in-lab testing, on-site inspection, certifications and technical services; ownership moves include phased share repurchases-3 million shares for CNY 63.5054 million (2023) and 5 million for CNY 71.4995 million (2024), a proposed 2-3 million share buyback in July 2024, and the August 2025 termination of a fourth employee stock ownership plan-underscoring CTI's strategic financial and governance actions as it integrates AI, data analytics and regulatory partnerships to build trust across global supply chains.
Centre Testing International Group Co. Ltd. (300012.SZ): Intro
Centre Testing International Group Co. Ltd. (300012.SZ) is a China-founded testing, inspection, and certification (TIC) provider that has grown from a Shenzhen start-up (2003) into a global TIC platform serving consumer goods, industrial, pharmaceutical, agricultural and sustainability markets. The company combines laboratory testing, inspection, certification, and technical services with digital platforms and traceability solutions to support product compliance, quality assurance, and supply-chain transparency.- Founded: 2003 in Shenzhen, China.
- IPO: 2009 - first Chinese TIC company listed on the Shenzhen Stock Exchange (stock code 300012).
- Global footprint (2024): >160 laboratories; >260 offices across 90 cities.
- 2024 operating revenue: CNY 6.084 billion - +8.55% YoY.
| Metric | Value (2024) |
|---|---|
| Operating revenue | CNY 6.084 billion |
| Year-on-year growth | +8.55% |
| Estimated 2023 revenue | CNY 5.606 billion (derived) |
| Laboratories | >160 |
| Offices | >260 |
| Cities served | 90 |
| Primary sectors | Textiles & apparel, footwear, electronics, pharmaceuticals, agriculture, environmental sustainability |
- 2003: Established in Shenzhen, entering the TIC sector focused initially on textiles and consumer products testing.
- 2009: Listed on the Shenzhen Stock Exchange (300012.SZ), becoming China's first TIC company to IPO on that exchange.
- 2009-2024: Expanded service scope from product testing to inspection, certification, verification, sustainability and digital traceability; built an international footprint of labs and offices.
- Public company listed on Shenzhen Stock Exchange under code 300012.SZ.
- Governance follows PRC public company requirements with a board of directors and independent supervisory bodies; ownership is a mix of institutional investors, retail shareholders, and company insiders (public disclosure required for detailed holder list).
- Mission: Provide science-based testing, inspection, certification, and verification that enhance product safety, quality and supply-chain transparency.
- Strategic focus: Sector diversification (from textiles to pharma, electronics, agriculture), international expansion of laboratory and inspection capacity, and development of sustainability & traceability services.
- See detailed, forward-looking statements and values here: Mission Statement, Vision, & Core Values (2026) of Centre Testing International Group Co. Ltd.
- Laboratory testing: Chemical, physical, microbiological and performance testing across product categories; accredited labs perform standardized and customized test protocols.
- Inspection services: Pre-shipment, in-process and factory inspections to verify quality, quantity and compliance at manufacturing sites.
- Certification & verification: Management-system certification, product certification, sustainability claims verification (e.g., carbon, materials provenance).
- Digital & traceability solutions: Data platforms to record test results, batch traceability, and provide transparency for brands, retailers and regulators.
- Testing & laboratory services - fee-for-service model charging per test, scope, and complexity (core recurring revenue stream).
- Inspection & on-site services - time-and-materials or per-inspection fees charged to manufacturers, brands, or traders.
- Certification & verification - program fees, recurring surveillance audits, and renewals for management or product certifications.
- Value-added services - consulting, training, digital platform subscriptions and data services for supply-chain management and sustainability reporting.
- Operating revenue: CNY 6.084 billion (+8.55% YoY).
- Geographic scale: More than 160 laboratories and 260+ offices in 90 cities, supporting both domestic and international clients.
- Sector breadth: Textiles, apparel, footwear, electronics, pharmaceuticals, agriculture and environmental sustainability driving diversified demand.
Centre Testing International Group Co. Ltd. (300012.SZ): History
Centre Testing International Group Co. Ltd. (300012.SZ) was founded as a materials and product testing and certification services provider and developed into one of China's leading third‑party testing institutions, expanding into sectors including consumer goods, chemicals, electronics, construction materials and environmental testing. The company listed on the Shenzhen Stock Exchange under ticker 300012 and has pursued inorganic and organic growth while refining corporate governance and shareholder return mechanisms.- Primary business: third‑party testing, inspection and certification across multiple industry verticals.
- Listed entity: Shenzhen Stock Exchange, stock code 300012.
- Founder & chairman: Wan Feng (listed among top five shareholders as of June 30, 2025).
| Event | Period | Shares Repurchased | Total Cost (CNY) | Notes |
|---|---|---|---|---|
| Share repurchase - Phase I | Completed 2023 | 3,000,000 | 63,505,400 | First completed share buyback |
| Share repurchase - Phase II | Completed 2024 | 5,000,000 | 71,499,500 | Second completed buyback |
| Share repurchase - Phase III (proposal) | Initiated July 2024 | 2,000,000-3,000,000 | - | Proposed concentrated bidding repurchases |
| Employee stock ownership plan - Phase IV | Terminated August 2025 | - | - | Terminated due to operational infeasibility; cited protection of company, shareholders and employees |
- Repurchase totals (phases I & II): 8,000,000 shares for CNY 135,004,900 combined.
- Management stake: Founder Wan Feng remains a key controlling/influential shareholder among the top five as of 2025‑06‑30.
Centre Testing International Group Co. Ltd. (300012.SZ): Ownership Structure
Centre Testing International Group Co. Ltd. (300012.SZ) - a leading testing, inspection and certification (TIC) provider headquartered in China - positions itself around a clear mission and set of values that drive its governance, client relationships and commercial model.- Mission: 'Build Trust for a Better Life' - ensuring healthier, safer, and more sustainable economic development through independent verification and assurance.
- Core values: Integrity; Collaboration & Team Advancement; Lean; Innovation; Client Centricity.
- Sustainability focus: integrates science-based solutions and verification services to improve transparency and traceability across global value chains; recognized in industry sustainability initiatives and reporting frameworks.
- Service model: laboratory testing, inspection, certification, technical advisory and digital assurance services across sectors (foods, consumer goods, industrial, materials, environment, life sciences, electronics, automotive).
- Delivery network: combination of centralized labs, regional testing centers and joint ventures/partnerships to serve domestic and international clients.
- Revenue drivers: fee-for-service testing & inspection, recurring certification and inspection contracts, managed testing programs, and value-added technical services.
| Metric | Value (latest FY) |
|---|---|
| Revenue | RMB 5.2 billion |
| Net profit (attributable) | RMB 1.1 billion |
| Employees | ~12,000 |
| Market capitalization | RMB 70 billion |
| Major shareholder (largest single holder) | ~11.2% stake |
- Public listing: A-share listed on Shenzhen Stock Exchange (Ticker: 300012.SZ), with a diversified mix of institutional, retail and founder-related holdings.
- Major shareholders typically include founder/management holdings, strategic investors and state/industry-related entities - board oversight combines independent directors and executive management to steward quality control and growth.
- Capital allocation: reinvestment into lab expansion, digital platforms, M&A for capability expansion and sustainability verification services.
| Revenue stream | Characteristics | Typical margin profile |
|---|---|---|
| Laboratory testing | One-off and batch testing for manufacturers, importers, regulators | Moderate to high (scale & technical premium) |
| Inspection services | On-site inspections, supplier audits, pre-shipment checks | Moderate |
| Certification & assurance | Recurring certification programs, product and system certifications | High (recurring, subscription-like) |
| Consulting & technical services | Problem-solving, product development support, compliance advisory | Variable (project-based) |
Centre Testing International Group Co. Ltd. (300012.SZ): Mission and Values
Centre Testing International Group Co. Ltd. (300012.SZ) is a leading global provider of testing, inspection and certification (TIC) services. Founded in the early 2000s in China, CTI expanded rapidly through organic growth and targeted acquisitions to build a presence across consumer goods, industrial products and regulated sectors. Its stated mission emphasizes protecting consumer safety, enabling compliance, and promoting sustainable supply chains while delivering reliable, science-based testing and certification. For the company's formal statements, see Mission Statement, Vision, & Core Values (2026) of Centre Testing International Group Co. Ltd.- Mission: Deliver trusted scientific testing and certification that safeguards consumers, supports clients' global market access, and accelerates sustainability.
- Core values: Integrity, technical excellence, customer focus, innovation, and sustainability.
- Global footprint: Over 160 laboratories and more than 260 offices across 90 cities worldwide, enabling local sample intake, rapid turnaround and regional regulatory support.
- Service diversity: Testing and inspection across textiles, apparel, footwear, electronics, pharmaceuticals, agriculture, food safety, toys, chemicals, cosmetics and environmental sustainability programs.
- Workforce & expertise: A team of over 13,000 professionals, including qualified engineers, chemists, microbiologists and technical experts supporting method development and quality assurance.
- Volume and scale: Issues more than 4 million test and certification reports annually for over 100,000 clients, including more than 100 Fortune 500 companies.
- Strategic partnerships: Formal collaborations with regulatory bodies, standards organizations and industry associations to harmonize testing protocols and improve market acceptance.
- Technology integration: Uses artificial intelligence, machine learning and advanced data analytics to automate result interpretation, optimize lab workflows, detect anomalies and improve accuracy.
- Client engagement and sample submission - local office or courier intake.
- Test planning and scope definition - regulatory matrix and client requirements mapped.
- Laboratory testing or on-site inspection - standardized methods or customized protocols.
- Data processing and QA - AI-assisted analytics and human expert review.
- Report issuance and certification - secure digital reports and certificates delivered to clients and regulators.
- Post-issuance services - re-testing, surveillance inspection, corrective action verification.
- Testing services: Fee-for-service revenue from chemical, physical, microbiological and performance tests across sectors.
- Inspection services: On-site factory audits, pre-shipment inspections and supplier assessments billed per engagement.
- Certification and audit programs: Management system certification and product conformity programs with recurring fees.
- Supply chain and advisory services: Risk assessment, compliance consulting and remediation support.
- Digital and data services: Subscription and per-report fees for data platforms, compliance dashboards and automated reporting.
- Training and capacity building: Paid training programs for clients and regulators.
| Metric | Value |
|---|---|
| Laboratories | 160+ |
| Offices | 260+ |
| Cities served | 90 |
| Employees | 13,000+ |
| Annual reports issued | 4,000,000+ |
| Clients | 100,000+ |
| Fortune 500 clients | 100+ |
| Revenue model | Testing, inspection, certification, advisory, digital subscriptions |
- Public listing: Listed on the Shenzhen Stock Exchange (300012.SZ), with a mix of institutional and retail shareholders.
- Management and governance: Board-led corporate governance with audit and risk committees; executive leadership focused on international expansion and technology-led efficiency.
- Strategic investors and partnerships: Holdings include stakes and JV arrangements in specialized testing niches to extend service breadth and regulatory reach.
- Consumer goods & textiles: Large share of apparel and footwear testing for global brands and importers.
- Electronics & appliances: Safety and EMC testing supporting cross-border market entry.
- Healthcare & pharma: GMP and regulatory testing for APIs, excipients and finished dosage forms.
- Agriculture & food: Residue, contamination and quality testing for export compliance.
Centre Testing International Group Co. Ltd. (300012.SZ): How It Works
Centre Testing International Group Co. Ltd. (300012.SZ) monetizes a full ecosystem of testing, inspection, certification, calibration, audit, training and technical services across multiple industries. Its model combines standardized in-lab testing capacity with scalable on-site inspection teams, platform-enabled order routing, and value-added certification and advisory services that command higher margins.- Core revenue streams: fee-for-service testing & inspection, certification issuance and surveillance, calibration services, audit & training contracts, and long-term service agreements with OEMs and retailers.
- Service delivery mix: centralized laboratories for high-throughput testing, mobile labs and on-site inspection teams, and remote/IT-enabled reporting and data services.
- Clients: consumer brands, cross-border e‑commerce platforms, industrial manufacturers, pharmaceutical companies, healthcare providers, food processors, and government/regulatory bodies.
- Unit testing: per-sample or per-batch fees for product safety, hazardous substance, electromagnetic compatibility (EMC), environmental and reliability tests.
- Inspection and audit: per-inspection-day, per-audit, or subscription-based surveillance contracts for factories and supply chains.
- Certification: fixed fees for issuing CE, system (e.g., ISO), product and service certifications plus recurring surveillance fees and re-certification charges.
- Value-added programs: bundled test + certification + supply-chain assurance programs sold to retailers and platforms (often higher-margin, multi-year contracts).
| Segment | Typical Services | Revenue Contribution (approx.) |
|---|---|---|
| Trade Assurance | Pre-shipment inspection, e‑commerce buyer protection testing, export/import compliance | ~30% |
| Consumer Product Testing | Safety, hazardous substances (RoHS, REACH), EMC, reliability | ~25% |
| Industrial Testing | Materials testing, environmental testing, mechanical/structural reliability | ~20% |
| Life Sciences | Food safety testing, microbiology, toxicology | ~15% |
| Pharmaceuticals & Medical Services | GMP testing, medical device testing, clinical lab services, regulatory support | ~10% |
- Hazardous substance testing (RoHS, REACH): high throughput, repeat order frequency from electronics and toy manufacturers.
- Electromagnetic compatibility (EMC) and safety inspection for electrical and electronic products: specialized lab equipment enables premium pricing.
- Environmental security testing: VOCs, heavy metals, and biodegradability tests for packaging and materials suppliers.
- Reliability analysis and accelerated life testing: long-duration, high-value projects with OEMs.
- Certification services (CE, ISO, system/service/product certifications): recurring surveillance and consultancy upsell.
- Lab network density: owning/operating large regional labs reduces sample turnaround time and increases capacity utilization.
- On-site inspection force: flexible staffing for seasonal peaks and cross-border client needs.
- Technology integration: LIMS (Laboratory Information Management Systems), digital reporting, and remote monitoring reduce administrative cost and improve billing velocity.
- Cross-sell between segments: one customer's product-test engagement can lead to certification, factory audits and ongoing surveillance contracts.
| Metric | Typical Range / Target |
|---|---|
| Revenue per laboratory / region | RMB tens to hundreds of millions annually (scale-dependent) |
| Gross margin on testing services | 30-60% depending on specialization and automation |
| Recurring revenue (certifications, surveillance) | Important driver - typically 20-40% of service revenue |
| Utilization rate of lab capacity | Target >70% to optimize fixed-cost absorption |
| Average contract length (audit/certification) | 1-3 years with annual surveillance fees |
- Single-sample consumer product safety test: fixed fee per sample (common for e‑commerce sellers and small exporters).
- Factory audit plus annual surveillance: multi-stage fee (initial audit higher; surveillance lower recurring fees).
- Pharmaceutical/medical device testing: project-based pricing with milestone payments tied to regulatory deliverables.
- Diversification across five segments reduces exposure to single-industry cyclicality.
- Investment in specialized labs (EMC chambers, chemical and life-science suites) captures higher-margin work.
- Partnerships with platforms and major retailers drive repeat volume (trade assurance programs).
- Regulatory tailwinds (stricter safety/environment rules) increase demand for independent testing and certification.
Centre Testing International Group Co. Ltd. (300012.SZ): How It Makes Money
Centre Testing International Group Co. Ltd. (300012.SZ) operates as a provider of testing, inspection, certification, and related technical services across industries including consumer goods, electronics, chemicals, food, environmental protection, and sustainability verification. The company monetizes its expertise through fee-based laboratory testing, certification programs, inspection services, technical consulting, and digital verification platforms that support traceability in supply chains.- Primary revenue streams: laboratory testing fees, product certification, on-site inspection services, technical advisory and consultancy, and digital verification/subscription services.
- Geographic expansion focus: Asia-Pacific and Africa to capture rising demand tied to industrial growth and strengthening regulatory frameworks.
- Sustainability services: science-based verification and traceability solutions that command premium pricing and long-term contract revenues.
| Metric | Value (CNY) | Notes |
|---|---|---|
| Stock price (as of 2025-12-19) | 13.49 | SHSZ: 300012.SZ |
| Market capitalization | 22.57 billion | Market cap at stated date |
| TTM Revenue | 6.39 billion | Trailing twelve months; +7.95% YoY |
| TTM Net Income | 986.61 million | Net profit for TTM period |
| EPS (TTM) | 0.59 | Earnings per share |
| P/E Ratio | 22.90 | Price-to-earnings based on stated EPS |
| Projected FY 2023 Revenue Growth | ~20% | Company guidance supported by regulatory demand |
- Testing & laboratory services: standardized and bespoke tests billed per sample or project; volume scaling via industrial clients drives margins.
- Certification & inspection: recurring and one-time certification fees; inspections billed per engagement, often with multi-year renewals.
- Consulting & technical services: higher-margin advisory on compliance, product development, and sustainability roadmaps.
- Digital & verification services: subscription/licensing and pay-per-report models for traceability platforms and data services.
- Solid mid-cap position (CNY 22.57 billion market cap) with profitability (TTM net income CNY 986.61 million) and a P/E of 22.90 indicating growth expectations priced in.
- Revenue momentum: TTM revenue CNY 6.39 billion (+7.95% YoY) with historical guidance targeting ~20% growth for 2023-driven by stricter global standards and cross-border trade compliance.
- Growth levers: expansion into Asia-Pacific and Africa, scaling lab network, cross-selling certification to testing clients, and premium sustainability verification services.
- Risks: regulatory shifts, capex for lab expansion, and competition from global testing conglomerates.

Centre Testing International Group Co. Ltd. (300012.SZ) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.